These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10082505

  • 1. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells.
    Wang XQ, Vaziri ND.
    Hypertension; 1999 Mar; 33(3):894-9. PubMed ID: 10082505
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide.
    Vaziri ND, Wang XQ.
    Hypertension; 1999 Dec; 34(6):1237-41. PubMed ID: 10601124
    [Abstract] [Full Text] [Related]

  • 7. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin.
    d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS.
    Hypertension; 2007 May; 49(5):1142-8. PubMed ID: 17372034
    [Abstract] [Full Text] [Related]

  • 8. Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells.
    Vogel V, Kramer HJ, Bäcker A, Meyer-Lehnert H, Jelkmann W, Fandrey J.
    Am J Hypertens; 1997 Mar; 10(3):289-96. PubMed ID: 9056686
    [Abstract] [Full Text] [Related]

  • 9. Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase.
    Yu YB, Su KH, Kou YR, Guo BC, Lee KI, Wei J, Lee TS.
    Acta Physiol (Oxf); 2017 Feb; 219(2):465-477. PubMed ID: 27232578
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells.
    Beleslin-Čokić BB, Cokić VP, Wang L, Piknova B, Teng R, Schechter AN, Noguchi CT.
    Cytokine; 2011 May; 54(2):129-35. PubMed ID: 21324713
    [Abstract] [Full Text] [Related]

  • 13. Short-term exposure of erythropoietin impairs endothelial function through inhibition of nitric oxide production and eNOS mRNA expression in the rat pulmonary artery.
    Sultan F, Singh TU, Kumar T, Rungsung S, Rabha DJ, Vishwakarma A, Sukumaran SV, Kandasamy A, Parida S.
    Pharmacol Rep; 2017 Aug; 69(4):658-665. PubMed ID: 28527876
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits.
    Noguchi K, Yamashiro S, Matsuzaki T, Sakanashi M, Nakasone J, Miyagi K, Sakanashi M.
    Br J Pharmacol; 2001 Jun; 133(3):395-405. PubMed ID: 11375256
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
    Zhao X, Li X, Trusa S, Olson SC.
    Regul Pept; 2005 Dec 15; 132(1-3):113-22. PubMed ID: 16242794
    [Abstract] [Full Text] [Related]

  • 18. AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase.
    Su KH, Yu YB, Hou HH, Zhao JF, Kou YR, Cheng LC, Shyue SK, Lee TS.
    J Cell Physiol; 2012 Aug 15; 227(8):3053-62. PubMed ID: 22021095
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.